Victoria-Jungfrau Collection AG has been acquired by AEVIS Holding SA
The shareholders of Victoria Jungfrau Collection AG, (VJC) the Swiss group of luxury hotels, received a public takeover offer from AEVIS Holding SA (AEVIS), a Swiss investment group focusing on the healthcare sector, acquiring a majority shareholding for US$69.5 million.
The Victoria-Jungfrau Collection AG is a small but exclusive hotel group with a unique portfolio of luxury five-star hotels of long standing. Other hotels of the group include The Victoria-Jungfrau Grand Hotel & Spa in Interlaken, the Palace Luzern on the shores of Lake Lucerne, the Eden au Lac in Zurich and the renowned Bellevue Palace in Bern.
AEVIS invests in the healthcare, life sciences, services and lifestyle sectors. The firm wishes to progressively develop new sectors of activity, amongst others in the sector of outpatient surgical centers, radiology and dental medicine and hotel or hotel related activities.
Oaklins' team in Switzerland was mandated by the board of VJC to assist in the assessment of the bids from a financial perspective. It was imperative to focus on the interests of the company and the shareholders and to achieve a fair price, while taking into consideration the strategic plans for the target of each bidder. The competitive situation of two bidders resulted in a stepwise increase of the price.
Talk to the deal team
Related deals
Den Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreBayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn moreVastned Belgium has received a fairness opinion on its reverse cross-border merger with Vastned Retail
The committee of independent members of the Board of Directors of Vastned Belgium, a listed Belgium-based company, has obtained a fairness opinion in the context of a cross-border reverse merger with Vastned Retail, a listed Netherlands-based company.
Learn more